Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
In this free webinar, the featured speakers will discuss the considerations and challenges of developing a decentralized clinical trial (DCT) from a sponsor perspective and considerations for investigators. Attendees will learn how to operationalize a DCT trial, how real-time patient dosing is monitored and how digital biomarkers are measured.
TORONTO (PRWEB) October 13, 2020
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Telepsychiatry has always offered a tantalizing solution to the significant undertreatment of mental illness. With COVID-19, widespread stay-at-home measures and reduced offerings for face-to-face mental health services has skyrocketed the demand for in-home care and accelerated the promise of telepsychiatry.
Innovative decentralized or virtual trials are taking telepsychiatry in mental health research to the next level—that is, bringing it to the patient's home.
During this interactive discussion, panelists will highlight the patient journey for a fully decentralized major depressive disorder (MDD) trial, including methodology for centralized raters, real-time patient dosage monitoring, and patient behavior insights from measured digital biomarkers to evaluate depression. We will also share insights for effective recruitment of a diverse patient population using a digital approach to attract and then engage participants.
The decentralized or virtual research model has become the standard in the current climate and this shift is helping to unlock the promise of telepsychiatry.
Join Thuy Le Nguyen, MPH, Senior Associate Director, Boehringer Ingeheim, Christopher Reist, MD, MBA, Medical Director, Psychiatry and Behavioral Science, Science 37, Isaac Galatzer-Levy, PhD, Chief Scientific Officer, AiCure and Gary Sachs, MD, Clinical Vice President, Signant Health in a live webinar on Friday, October 23, 2020 at 9am EDT (1pm BST/UK).
For more information or to register for this event, visit The Promise of Telepsychiatry: Implications for Clinical Research in a Post-COVID Era.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
For the original version on PRWeb visit: https://www.prweb.com/releases/the_promise_of_telepsychiatry_implications_for_clinical_research_in_a_post_covid_era_upcoming_webinar_hosted_by_xtalks/prweb17461952.htm
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.